About Tergene Biotech Limited
Data last updated: 24 December 2025
Tergene Biotech Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Aurobindo Pharma Ltd. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 07 March 2008, the company has been in operation for over 18 years.
Registered with ROC Hyderabad under CIN U24230TG2008PLC113178.
Capital: an authorised share capital of ₹47.5 Cr and a paid-up capital of ₹47.15 Cr. Formerly known as Tergene Biotech Private Limited. It is led by directors including Umesh Krishnamoorthy and Mosuvan Kuppusamy.
Last AGM: 22 September 2025. Financial statements filed for year ended 31 March 2025. Office: Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.94 Lakh, a decline of 98% compared to the previous year.
It operates as a subsidiary of Aurobindo Pharma Ltd.
The company is associated with 2 brands - Aurobindo Pharma, Tergene Biotech. As per MCA filings, the company has satisfied charges of ₹1.18 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tergene.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Tergene Biotech Limited
Tergene Biotech Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230TG2008PLC113178, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2008PLC113178 | Current |
| U24230TN2008PTC066737 | Previous |
| U24230TG2008PTC113178 | Previous |
Associated Brands with Tergene Biotech Limited
Tergene Biotech Limited operates two associated brands: Aurobindo Pharma and Tergene Biotech. These brands represent Tergene Biotech Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Generic biocatalytic solutions are provided for pharmaceutical applications. | aurobindo.com | |
| Bio-conjugate technologies for bacterial vaccines and conjugates are developed. | tergene.com |
Competitors & Alternatives of Tergene Biotech Limited
Brands and companies operating in the same space as Tergene Biotech Limited include Biological E, Concord Biotech, BDR Pharmaceuticals Internationals and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Biological E
|
Vaccines and therapeutics for multiple diseases are developed and marketed. | Hyderabad, India, India | 1953 |
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
BDR Pharmaceuticals Internationals
|
APIs and finished products are developed and manufactured. | Mumbai, India, India | 2003 |
Insmed
|
Developer of small molecule inhibitors for rare lung diseases | Bridgewater, United States, United States | 1999 |
Vaxart
|
Developer of therapeutic solutions for treating multiple infectious diseases | San Francisco, United States, United States | 2004 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Eligo Bioscience
|
In vivo gene editing technology is developed for microbiome modulation. | Paris, France, France | 2014 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Affinivax
|
Technology-based conjugate vaccines against infectious diseases are developed. | Cambridge, United States, United States | 2013 |
Business Activity of Tergene Biotech Limited
Tergene Biotech Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Tergene Biotech Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Tergene Biotech Limited
Tergene Biotech Limited is audited by G P M & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G P M & Associates | Locked | Locked | Locked |
Complete auditor history for Tergene Biotech Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Tergene Biotech Limited
Tergene Biotech Limited is currently managed by 5 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Umesh Krishnamoorthy
Also directs:
Tergene Biotech Limited
|
Director | 28 Jun 2023 | 3 Years 0 Months | Current |
|
Mosuvan Kuppusamy
Also directs:
Tergene Biotech Limited
|
Director | 07 Mar 2008 | 18 Years 4 Months | Current |
|
Sivakumaran Meenakshisunderam
Also directs:
Tergene Biotech Limited, Curateq Biologics Private Limited, Auro Peptides Limited and 3 more
|
Director | 01 Apr 2015 | 11 Years 3 Months | Current |
|
Kuppusamy Sathyan
Also directs:
Tergene Biotech Limited, Samies Technologies Private Limited
|
Director | 07 Mar 2008 | 18 Years 4 Months | Current |
|
Santhanam Subramanian
Also directs:
Tergene Biotech Limited, Eugia Steriles Private Limited, Aurobindo Pharma Ltd and 5 more
|
Director | 26 Aug 2016 | 9 Years 10 Months | Current |
Financials of Tergene Biotech Limited FY 2025 filings available
Tergene Biotech Limited reported revenue of ₹8.94 Lakh (down 98.00% YoY) for FY 2025.
Ten-year financial statements for Tergene Biotech Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Tergene Biotech Limited
Shareholding and ownership data for Tergene Biotech Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Tergene Biotech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2012 | Biotechnology Industry Research Assistance Council | ₹1.18 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Tergene Biotech Limited
View historical data on people associated with Tergene Biotech Limited, including employment history and EPFO contributions.
Employee and EPFO history for Tergene Biotech Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Tergene Biotech Limited
GST registrations and filing compliance for Tergene Biotech Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Tergene Biotech Limited
Credit ratings, litigation, and regulatory alerts for Tergene Biotech Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Tergene Biotech Limited
MSME payment history for Tergene Biotech Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Tergene Biotech Limited
Corporate group structure for Tergene Biotech Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Tergene Biotech Limited
MCA filings and documents for Tergene Biotech Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Tergene Biotech Limited
Recent News on Tergene Biotech Limited
Frequently Asked Questions about Tergene Biotech Limited
Tergene Biotech Limited is an active public limited company in the life sciences sector based in Hyderabad, Telangana, India. It was incorporated on 07 March 2008 (18+ years old) and is registered under CIN U24230TG2008PLC113178.
Tergene Biotech Limited reported revenue of ₹8.94 Lakh for FY 2025 (down 98.00% YoY).
The current directors of Tergene Biotech Limited are:
- Umesh Krishnamoorthy - Director
- Mosuvan Kuppusamy - Director
- Sivakumaran Meenakshisunderam - Director
- Kuppusamy Sathyan - Director
- Santhanam Subramanian - Director
The primary industry of Tergene Biotech Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Tergene Biotech Limited can be reached at the registered office: Galaxy Floors 22 – 24 Plot No. 1 Survey No. 831 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032, or through the website tergene.com.
The authorised capital is ₹47.5 Cr, and the paid-up capital is ₹47.15 Cr.